Notices and Reminders
Job Opening: Associate Vice President for Research Space and Facilities
The Office of the Vice President for Research seeks applications for the position of Associate Vice President for Research Space and Facilities. The candidate must hold an academic appointment at OUHSC and be an Associate or Full Professor with a demonstrated record of leadership at the Department/College or University level. The primary job responsibilities of this position include:
- Development, implementation, and oversight of University policies and procedures related to Institutional Core Facilities and Research Space Allocation
- Provides operational oversight for University Core Facilities and Space, including Capital Improvements
- Must have 2 years background with development of blueprints and interaction with architecture and engineering groups on and off campus
- Serves on new lab and building committees related to research renovation/development and helps to interview A&E groups for specific projects
To view the complete position details, please visit https://apply.interfolio.com/125271. Deadline to submit applications is May 26, 2023.
Reminder: ORA would like to provide a reminder that any general or proposal-specific inquiries (what/when to route, information on the form such as participants, attachments, etc.) should be sent to your Sponsored Programs Administrator (SPA) in ORA. If unsure, visit the ORA Website to determine who that is: https://research.ouhsc.edu/research-administration/find-sponsored-program-administrators
If you are unsure of who to contact in ORA or need general triaging, please send your inquiry to hscora@OUHSC.edu. This is the only general mailbox used for triaging questions.
Please send any SoonerTrack system-specific inquiries such as workflow, stuck forms, user access, etc. to SoonerTrack Help Desk at soonertrackhelpdesk@ouhsc.edu. And don’t forget about the SoonerTrack support site! https://research.ouhsc.edu/research-administration/soonertrack-ii-support
Reminder: Please be reminded that anyone who is OUHSC personnel and has effort on the grant needs to be added to the Participants grid on the SoonerTrack Request Form. All the information included in the Participants grid (e.g. participant type, name, total effort %, etc.) must match the grant. Business Managers retain primary responsibility for ensuring that all this information is correct.
Workshops and Seminars
International Ovarian Cancer Research Consortium in conjunction with the International Society of Precision Cancer Medicine
Date: June 12 - 13, 2023 at the Omni Hotel in Oklahoma City
Description: The 2023 Meeting has been organized to provide a comprehensive overview of clinical challenges, research breakthroughs, and therapeutic innovations in two major thematic areas of cancer research, namely ovarian cancer and precision cancer medicine. This is an international conference consisting of distinguished speakers from Canada, China, India, Italy, Japan, Korea, Taiwan, Thailand, and USA with expertise in cancer biology, cancer genomics, targeted therapy, therapy resistance, personalized medicine, and cancer bioinformatics. Highly insightful papers will be presented in the form of keynote address, plenary lectures, and thematic sessions.
We will host a dinner on June 12 at the Oklahoma History Center, please RSVP at: https://ousurvey.qualtrics.com/jfe/form/SV_3n6TJfwiZzNiOFM
Registration: https://ousurvey.qualtrics.com/jfe/form/SV_88LaN8tifTzNUN0
Contact: Emily Hulseberg emily-hulseberg@ouhsc.edu
Spring 2023 NSF Virtual Grants Conference
Date: June 5 – 8, 2023
Description: The NSF Grants Conference is designed to give new faculty, researchers, and administrators key insights into a wide range of current issues at NSF. NSF staff will provide up-to-date information about policies and procedures, specific funding opportunities and answer attendee questions.
Registration: https://nsfpolicyoutreach.com/
The USF Summer Grant Writing Workshops
Date: Jun 5, 2023 - Jul 28, 2023
Description: The USF Summer Grant Writing Workshops program is tailored for early career grant seekers of all disciplines. At the core of this course is to advance the understanding of how to prepare a clear, comprehensive, compelling grant proposal. Participants are encouraged to identify a grant opportunity early in the program, draft a proposal, and participate in mock peer review.
This is an 8-week workshop series. It will be offered in a virtual format. Hosted, recorded sessions will be provided to registered participants.
Registration: https://grant.catalog.instructure.com/browse/all/grants/courses/summer-grant-writing-workshops-program-2023-2501
OUHSC Funding Opportunities
Oklahoma Center of Medical Imaging for Translational Cancer Research Centers of Biomedical Research Excellence (COBRE) Call for Proposals 2023 – 2024 Pilot Project Grants
Description: The Oklahoma Center of Medical Imaging for Translational Cancer Research invites applications for the Pilot Project Grants. The purpose of the pilot grant program is to provide seed funding to help researchers to test new research hypothesis and generate preliminary data for future extramural research grant application. The proposal should fit into the central research theme of this COBRE, which is to pursue translational biomedical research to help increase cancer detection/diagnosis accuracy or treatment efficacy by developing and/or applying novel medical imaging techniques or quantitative imaging markers. All types of studies using retrospective human subject image data, vertebrate animal models, cancer cell line models and/or the dedicated imaging phantoms are accepted.
If you have any questions regarding this COBRE pilot project program, please contact Javier Jo (javierjo@ou.edu).
Application deadline: May 27, 2023
Link to Full Announcement: Please see the attached flyer.
New Clinical Study Opportunities
Please note this is NOT a solicitation for study subjects
Several Pharmaceutical companies are looking for Principal Investigators to participate in the following clinical studies:
- Alkermes Schizophrenia or Bipolar I Disorder Protocols ALKS 3831-A312 and ALKS 3831-A313
- Organon Protocol: OG-8369-301 Indication: Exocrine Pancreatic Insufficiency (EPI) This is a placebo-controlled, crossover study of adult participants with Exocrine Pancreatic Insufficiency Associated with Diabetes Mellitus without a chronic pancreatitis diagnosis.
- Organon Protocol: OG-8369-303 Indication: Exocrine Pancreatic Insufficiency (EPI) This is a comparator-controlled study of adult participants with EPI resulting from chronic pancreatitis or a partial pancreatectomy investigating a new PERT which may help reduce total pill burden for study participants.
- Janssen_Post-ACS Survey_Protocol 70033093ACS3003
- OG-6219-P001_Organon_Endometriosis_Global_13Mar23_GSID
- Protocol Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm, 3-Period Study to assess the Efficacy and Safety of New Formulation of Oral Cladribine compared with Placebo in Participants with Generalized Myasthenia Gravis (MyClad)
- Target population: adult patients with MGFA Class II to IVa gMG
Please contact Scott Davis at scott-davis@ouhsc.edu if you would like to receive more information on any of these studies. The resulting confidentiality and/or clinical study agreement will need to be routed to the Office of Research Administration.
Office of Technology Commercialization presents the following opportunity for researchers to engage with industry
(click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).
- A multinational pharmaceutical company is seeking natural ingredients to improve sleep as alternative or add-on therapies to Melatonin. Ingredients targeting the orexin pathway either directly or indirectly are of highest interest; ingredient must be for oral delivery in food grade (not a drug). All sources of natural compounds are of interest. Submission entails completion of non-confidential application. (deadline 06/05).
- AstraZeneca is seeking applicants from final year MD and/or PhD students or Postdoctoral Researchers within three years of receiving their advanced postgraduate degree for a fully funded post-doctoral position. Proposal in should focus on innovative technologies to improve development of novel therapeutics and treatment approaches or be an innovative idea in one of AZ’’s focus areas (cardiovascular, renal and metabolic disease, respiratory and immunology, common infectious and rare diseases). Successful candidates will be awarded a fully funded postdoctoral position. Submission entails completion of non-confidential application. (deadline 06/30).
NIH Notices
- Special Emphasis Notice: AHRQ Announces Interest in Health Services Research to Advance Health and Healthcare Equity
(NOT-HS-23-013)
- Notice Regarding the Data Management and Sharing Plan for Applications Submitted to PAR-20-299 or PAR-20-300, Translational Research in Maternal and Pediatric Pharmacology and Therapeutics
(NOT-HD-23-014)
- Technical and Business Assistance (TABA) Consulting Services for National Institutes of Health (NIH) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II or Phase IIB Awardees
(NOT-OD-23-125)
- Request for Information (RFI): Research Questions to Inform Development of Potential NIDCD Mission Specific Ancillary Collaborations with the All of Us Research Program
(NOT-DC-23-012)
- Request for Information: Prioritization of Drug, Vaccine, and Dietary Supplement Research Needs for Pregnant, Postpartum, and Lactating Persons
(NOT-HD-23-013)
- Notice of Change to Key Dates Listed in RFA-AG-24-011, "Research Coordinating Center on the Exposome and AAD/ADAARD: Elucidating the Role of Social and Behavioral Determinants of Health in AD/ADRD Etiology and Disparities (U24 Clinical Trial Not Allowed)"
(NOT-AG-23-023)
- Notice of Participation of the NIAID in NOT-OD-22-137, Notice of Special Interest (NOSI): Availability of Administrative Supplements for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
(NOT-AI-23-047)
- Notice to Extend the Expiration Date for PA-21-071 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
(NOT-OD-23-128)
- Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Trial Optional)
(NOT-CA-23-066)
- Notice of Intent to Publish a Funding Opportunity Announcement for Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional)
(NOT-CA-23-067)
- Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional)
(NOT-CA-23-068)
- Notice of Special Interest (NOSI): Maximizing the Scientific Value of Secondary Analyses of Existing Cohorts and Datasets in Order to Address Research Gaps and Foster Additional Opportunities in Aging Research
(NOT-AG-23-020)
- Notice of Special Interest (NOSI): Analyses of CALERIE Datasets and Biospecimens to Elucidate the Biological Effects and the Behavioral and Psychological Aspects of Sustained Caloric Restriction in Humans
(NOT-AG-23-024)
- Notice of Special Interest (NOSI): Administrative Supplements for Ethical Considerations in Artificial Intelligence and Machine Learning (AI/ML) at NIMHD-Funded Research Centers in Minority Institutions (RCMI)
(NOT-MD-23-013)
- Notice of Special Interest (NOSI): Administrative Supplements to Enhance Institutional Data Science Capacity
(NOT-OD-23-123)
- Notice of Special Interest (NOSI): Phase 2 of the U.S.-South Africa Program for Collaborative Biomedical Research, Administrative Supplement Opportunity for South African International Research Training Grants (D43; U2R)
(NOT-TW-23-005)
- Notice of Special Interest (NOSI) for Administrative Supplements to Fogarty International Center's (FIC) Training Grants to Promote Diversity, Equity, and Inclusion (DEI).
(NOT-TW-23-006)
NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted). The letters of intent will be reviewed and a single application will be chosen for submission from the University.
NIH Funding Opportunities
- NINDS Postdoctoral Mentored Career Development Award (K01 Clinical Trial Required)
(PAR-23-142)
Application Receipt Date(s): May 07, 2024
- NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed)
(PAR-23-143)
Application Receipt Date(s): May 07, 2024
- Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed)
(PAR-23-174)
Application Receipt Date(s): November 16, 2024
- Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)
(PAR-23-177)
Application Receipt Date(s): June 19, 2025
- Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
(PAR-23-180)
Application Receipt Date(s): December 07, 2024
- Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional)
(PAR-23-190)
Application Receipt Date(s): December 22, 2025
- HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)
(PAR-23-191)
Application Receipt Date(s): December 08, 2025
- Limited Competition: Renewal of the Longevity Consortium (U19 Clinical Trial Not Allowed)
(RFA-AG-24-017)
Application Receipt Date(s): October 18, 2023
- Renewal-Local Food Producer Outreach, Education and Training to Enhance Food Safety and FDA Food Safety Modernization Act (FSMA) Compliance (U01) Clinical Trial Not Allowed
(RFA-FD-23-031)
Application Receipt Date(s): July 11, 2023
- BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
(RFA-MH-23-290)
Application Receipt Date(s): June 07, 2023
- BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
(RFA-MH-23-295)
Application Receipt Date(s): Multiple dates, see announcement.
- HEAL Initiative Partnerships to Advance INterdisciplinary (PAIN) Training in Clinical Pain Research: The HEAL PAIN Cohort Program (T90/R90 Independent Clinical Trial Not Allowed)
(RFA-NS-24-015)
Application Receipt Date(s): September 26, 2023
- INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
(RFA-OD-23-016)
Application Receipt Date(s): July 01, 2023
Other Funding Opportunities
Telligen Community Initiative (TCI) 2023 Request for Proposals: Strengthening Families and Communities (Social Determinants Of Health)
Description: With this Request for Proposals, TCI seeks to emphasize the integration of childhood, family, and community health in new ways for our foundation. TCI wants to resource efforts that advance optimal physical, mental, and social health and well-being for families, children and youth in the four states TCI supports. We will prioritize reaching caregivers of color and families with limited financial resources – in rural, frontier, or urban settings. Programs supported can be advancing established evidence-based programs or the refinement of emerging and promising community-based practices. Below represents the targeted areas TCI wants to advance with our philanthropy in this RFP within the social determinants of health. It is also accompanied by illustrative examples of what programmatic efforts and success indicators could be built around. The potential focus or indicators of success are not prescribed or limited to what could be requested for TCI consideration by an applicant. They are just examples meant to stimulate thought and meet your community needs and work where our funding could be most impactful to your plan. That said, the overall part of the social determinants of health we want to position our funding around is strengthening families and efforts that could build family and community resiliency and enhancement of protective factors. These are the only funding themes we intend to support with TCI grant awards.
Cystic Fibrosis (CF) Foundation: PTAC Collaborative Research Grant
Description: The PTAC Collaborative Research Grant supports integrated, multi-investigator collaborative research programs that will advance the priorities of the PTAC Initiative. A Collaborative Research Grant proposal must have at least two, and may include up to four, related research projects that share a well-defined theme and overall objective. This program has a budget cap of $1M DC plus 12% IDC. Applicants must speak with CFF program staff prior to submitting a proposal. For questions please contact John Sheridan (jsheridan@cff.org).
The Robert Wood Johnson Foundation: Health Equity Scholars for Action (HES4A)
Description: Health Equity Scholars for Action (HES4A) supports the career development and academic advancement of historically underrepresented researchers conducting health equity research.
HES4A scholars receive:
- Funding for research on potential solutions to improve health, equity, and well-being for all;
- Coaching and mentorship to help develop and strengthen technical skills and explore career opportunities; and,
- A professional network of community partners, researchers, public health practitioners, and funders committed to advancing the health equity research field.
LOI Deadline: May 31, 2023
Link to Full Announcement: https://www.rwjf.org/en/grants/active-funding-opportunities/2023/health-equity-scholars-for-action.html
The Chan Zuckerberg Initiative (CZI): Request for Applications: Measuring Metabolism Across Scales
Description: The Chan Zuckerberg Initiative (CZI) seeks to support two-year collaborative research projects focused on measuring metabolism across organelles and cells. The ability to characterize temporally and spatially the broad molecular profiles, heterogeneity, and phenotypic diversity of organelles and cells and how they interact within and as systems are key to measuring human biology, understanding disease mechanisms, and finding treatments and cures. This Request for Applications (RFA) aims to accelerate innovative discoveries in metabolism and metabolic physiology in health and disease.
Application Deadline: June 1, 2023
Link to Full Announcement: https://chanzuckerberg.com/rfa/measuring-metabolism-across-scales/
DoD Lung Cancer Research Program (LCRP)
- Patient-Centered Outcomes and Survivorship Award (PCOSA)
Pre-Application (Letter of Intent): July 20, 2023
Application: August 10, 2023
Link to Full Announcement: https://cdmrp.health.mil/funding/lcrp
CF Foundation: NIH K-Boost Award
Description: This award is designed to provide a $50,000 per year supplement to an NIH K-award that has a CF focus.
Application Deadline: Rolling applications must be submitted online at awards.cff.org.
For questions, please contact Elizabeth Yu (eyu@cff.org).
Link to Full Announcement: https://www.cff.org/researchers/cf-foundation-nih-k-boost-award
CF Foundation/NIH K-Unfunded Award
Description: This award is designed to provide support for investigators with meritorious NIH K applications that were not selected for funding as they revise and resubmit.
Application Deadline: Rolling applications must be submitted online at awards.cff.org.
For questions, please contact Elizabeth Yu (eyu@cff.org).
Link to Full Announcement: https://www.cff.org/researchers/cf-foundationnih-k-unfunded-award
CF Research Additional Mentoring Program (RAMP)
Description: The RAMP Award is designed to enable promising early-career physician scientists seeking additional research mentoring outside of their home academic institutions to enhance their clinical or translational research proficiency and support their development of the necessary clinical research capabilities to become independent investigators.
Application Deadline: Applications must be submitted online at awards.cff.org by May 23, 2023.
For questions, please contact Elizabeth Yu (eyu@cff.org).
Link to Full Announcement: https://www.cff.org/researchers/research-additional-mentoring-program-award
The Lung Cancer Research Foundation (LCRF) – Daiichi Sankyo – AstraZeneca Research Grant on Antibody Drug Conjugates
Description: LCRF is pleased to announce a collaboration with Daiichi Sankyo and AstraZeneca to fund up to three research grants focused on antibody drug conjugates (ADCs) to improve outcomes for people with lung cancer. This competitive funding mechanism will provide up to $270,000 in funding over a two-year period.
The LCRF - Daiichi Sankyo - AstraZeneca Research Grant on Antibody Drug Conjugates will develop further understanding of the mechanism of action and biomarkers for TROP2 directed ADCs in lung cancer and HER2 directed ADCs in HER2 mutant NSCLC and primary and acquired resistance to TROP2 directed and HER2 directed ADCs.
Application Deadline: May 31, 2023
Link to Full Announcement: Complete details including eligibility criteria and application instructions may be found on the LCRF website.
DoD Ovarian Cancer Research Program (OCRP)
- Clinical Translational Research Award
- Clinical Trial Award
- Ovarian Cancer Clinical Trial Academy - Leadership Award
Pre-Application: May 26, 2023
Application: July 21, 2023
Link to Full Announcement: https://cdmrp.health.mil/funding/ocrp
DoD Epilepsy Research Program (ERP)
Pre-Application (Letter of Intent): May 19, 2023
Application: June 23, 2023
Link to Full Announcement: https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=495101